Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study

Jorge J. Castillo, Mark Bower, Jérémy Brühlmann, Urban Novak, Hansjakob Furrer, Paula Y. Tanaka, Caroline Besson, Silvia Montoto, Kate Cwynarski, Jeremy S. Abramson, Samir Dalia, Michele Bibas, Joseph M. Connors, Michael Furman, Minh Ly Nguyen, Timothy P. Cooley, Brady E. Beltran, Jaime A. Collins, Julie M. Vose, Blanca XicoyJosep Maria Ribera

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study'. Together they form a unique fingerprint.

Medicine & Life Sciences